Strategic Growth Lafayette Instrument has a history of strategic acquisitions, including Limestone Technologies, Campden Instruments, Avisoft, and ongoing private equity backing. This signals potential for cross-sell of complementary polygraph and neuroscience instruments, as well as opportunities to partner on integrated research solutions.

Expansion Readiness Recent news indicates plans to integrate pulse transit time technology into a new instrument for 2026, suggesting openness to product line expansion and updated data capture capabilities that could benefit customers needing advanced physiological measurement and analysis.

Bioacoustics Opportunity Acquisition of Avisoft Bioacoustics expands capabilities in ultrasonic microphones and animal call recording software, opening doors to sales of high-end sensing hardware, acoustics software partnerships, and related calibration or maintenance services.

Global & Private Equity As a Branford Castle Partners portfolio company with international acquisitions, there is likely ongoing demand for scalable manufacturing services, equipment modernization, and custom fabrication—presenting upsell opportunities for sheet metal and machining capabilities.

Mid-market Fit With revenue in the $10–$25 million range and a lean employee base, Lafayette Instrument appeals to mid-market institutions and specialized labs that value durable, long-term instrumentation; a targeted outreach to polygraph, neuroscience, and life-science research customers could yield repeat procurement and service contracts.